Pharmaceutical company.
Active 2008–2026. The register lists this client once for every firm that files on its behalf; all 18 of its records are shown together here.
These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | CGCN GROUP, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2026 | MARSHALL & POPP, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$60,000 | |
| 2026 | MCLARTY INBOUND LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$90,000 | |
| 2026 | AVENUE SOLUTIONS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$60,000 | |
| 2026 | TARPLIN, DOWNS & YOUNG, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$80,000 | |
| 2026 | ALSTON & BIRD LLP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2026 | STANTON PARK GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2026 | ALB SOLUTIONS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2026 | TIBER CREEK GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$60,000 | |
| 2026 | EMPIRE CONSULTING GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 |
| Firm | Filings | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED IN-HOUSE | 79 | $36,200,000 |
| TARPLIN, DOWNS & YOUNG, LLC | 82 | $4,820,000 |
| TIBER CREEK GROUP | 65 | $3,970,000 |
| STANTON PARK GROUP | 68 | $2,970,000 |
| WILLIAMS AND JENSEN, PLLC | 36 | $990,000 |
| EMPIRE CONSULTING GROUP | 22 | $980,000 |
| AVENUE SOLUTIONS | 15 | $800,000 |
| CAPITOL COUNSEL LLC | 20 | $730,000 |
| CORNERSTONE GOVERNMENT AFFAIRS, INC. | 15 | $550,000 |
| CGCN GROUP, LLC | 9 | $470,000 |
| CROSSROADS STRATEGIES, LLC | 15 | $440,000 |
| MARSHALL & POPP, LLC | 8 | $400,000 |
| MCLARTY INBOUND LLC | 8 | $290,000 |
| FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 6 | $210,000 |
| HOLLAND & KNIGHT LLP | 9 | $150,000 |
| ALB SOLUTIONS | 4 | $150,000 |
| SALT POINT STRATEGIES | 6 | $140,000 |
| ALSTON & BIRD LLP | 4 | $120,000 |
| Issue | Activities |
|---|---|
| Health Issues | 393 |
| Medicare/Medicaid | 219 |
| Budget/Appropriations | 151 |
| Taxation/Internal Revenue Code | 126 |
| Medical/Disease Research/Clinical Labs | 66 |
| Pharmacy | 38 |
| Copyright/Patent/Trademark | 27 |
| Trade (domestic/foreign) | 20 |
| Defense | 15 |
| Science/Technology | 4 |
| Veterans | 4 |
| District of Columbia | 1 |
| Homeland Security | 1 |